Indivior says remote working hits sales in Covid-19 crisis
8th Apr 2020 10:11
(Sharecast News) - Indivior said remote working was damaging sales as the drugs company withdrew its financial guidance during the Covid-19 crisis.
Read moreIndivior warns of annual loss as Suboxone sales plunge
13th Feb 2020 10:42
(Sharecast News) - Indivior warned it would suffer a loss this year after collapsing sales of its controversial Suboxone opioid-addiction treatment caused profit to fall more than a third in 2019.
Read moreIndivior surges as it upgrades revenue guidance again
15th Oct 2019 10:17
(Sharecast News) - Indivior shares rallied on Tuesday after the pharmaceuticals company lifted its revenue outlook again following a stronger-than-expected performance from its opioid-addiction treatment Suboxone.
Read moreFTSE 250 movers: Indivior dives, Metro Bank chugs upward
17th May 2019 14:54
(Sharecast News) - London's FTSE 250 was down 0.42% at 19,448.80 in afternoon trade on Friday, with Indivior's shares at the head of the index's fallers.
Read moreDirector dealings: Indivior execs snap up shares
15th May 2019 15:41
(Sharecast News) - Indivior chief executive officer Sean Thaxter bought 100,000 shares at 44.64p each on Tuesday, leaving him with an interest of just over 1.6m shares.
Read moreIndivior surges as directors buy up shares
15th May 2019 14:15
(Sharecast News) - Indivior shares got a boost on Wednesday as the drug developer revealed that some of its directors had been buying up the stock.
Read moreIndivior signs agreement to sell schizophrenia drug in Canada
9th May 2019 12:37
(Sharecast News) - Indivior, which makes opioid addiction treatment Suboxone, has entered into an exclusive license agreement with specialty pharmaceutical company HLS Therapeutics for the commercialisation rights to schizophrenia drug Perseris (risperidone) in Canada.
Read moreFTSE 250 movers: Ultra Electronics charges higher, Intu crumbles
3rd May 2019 14:29
(Sharecast News) - London's FTSE 250 index was up 0.16% at 19,718.42 in afternoon trade on Friday, with Ultra Electronics leading the index higher.
Read moreIndivior warns of potential full-year loss as quarterly profit eases
2nd May 2019 13:32
(Sharecast News) - Drug maker Indivior, which has been accused by the US Department of Justice of fraudulently marketing an addiction treatment, has warned it could slide into the red this year.
Read moreReckitt Benckiser Q1 sales fall short of estimates
2nd May 2019 07:20
(Sharecast News) - Consumer goods group Reckitt Benckiser posted a small uptick in first-quarter like-for-like revenue on Thursday after what it called a "slow" start to the year, which saw sales dented by a weak cold and flu season.
Read moreFTSE 250 movers: Funding Circle falters, Ferrexpo flies
1st May 2019 15:03
(Sharecast News) - London's FTSE 250 index was down 0.10% at 19,805.33 in afternoon trade on Wednesday, with Funding Circle leading the index downwards.
Read moreFTSE 250 movers: Games Workshop rolls higher, Plus500 plummets
12th Apr 2019 15:15
(Sharecast News) - London's FTSE 250 index was 0.33% higher at 19,684.98 in afternoon trade on Friday, with Games Workshop propelling the index upwards.
Read moreIndivior crashes after indictment by US federal grand jury, drags Reckitt lower
10th Apr 2019 08:06
(Sharecast News) - A US jury has indicted Indivior for fraudulently flogging its Suboxone Film drug as a safer alternative to rival treatments for opiod addiction.
Read moreIndivior publishes new research on opioid use disorder
8th Apr 2019 09:18
(Sharecast News) - Indivior has published two pieces of clinical research supporting its treatments for opioid use disorder.
Read moreIndivior publishes new research on opioid use disorder
8th Apr 2019 09:18
(Sharecast News) - Indivior has published two pieces of clinical research supporting its treatments for opioid use disorder.
Read more